What do we know about COVID-19 media coverage and African stock markets? A time-varying connectedness analysis

被引:0
|
作者
Bossman, Ahmed [1 ]
Teplova, Tamara [2 ]
Umar, Zaghum [3 ,4 ]
机构
[1] Univ Cape Coast, Dept Finance, Sch Business, Cape Coast, Ghana
[2] Natl Res Univ, Higher Sch Econ, Fac Econ Sci, Dept Financial Market Infrastruct, Moscow, Russia
[3] Zayed Univ, Coll Business, Abu Dhabi, U Arab Emirates
[4] Lebanese Amer Univ, Adnan Kassar Sch Business, Beirut, Lebanon
关键词
African stock markets; coronavirus disease; COVID-19; media coverage; public mood; C32; G10; G11; N27; SOCIAL MEDIA; COMMODITIES; SENTIMENT; OIL;
D O I
10.1080/00036846.2024.2322571
中图分类号
F [经济];
学科分类号
02 ;
摘要
In this study, we explore the role of media coverage in the connectedness between African stock markets during the COVID-19 pandemic. Using the time-varying parameter autoregression connectedness metric and the Media Coverage Index (MCI), we analyse return and volatility connectedness between African stocks from January 2020 to October 2022. Our findings reveal that the MCI significantly drives risk transmission and financial market contagion from the global market to African markets. We document a peak in return (volatility) connectedness at 73% (55%) during the height of the pandemic in March 2020. The MCI transmits return shocks to all African stock markets except South Africa and Botswana, and volatility spillovers to all African markets. Our analysis suggests potential diversification attributes for stocks from Ghana, Mauritius, and Nigeria, which are strictly net receivers throughout the pandemic period. These findings have important implications for risk management, asset allocation, and market regulation decisions.
引用
下载
收藏
页数:15
相关论文
共 50 条
  • [41] Erythema Multiforme and COVID-19: What Do We Know?
    Bennardo, Luigi
    Nistico, Steven Paul
    Dastoli, Stefano
    Provenzano, Eugenio
    Napolitano, Maddalena
    Silvestri, Martina
    Passante, Maria
    Patruno, Cataldo
    MEDICINA-LITHUANIA, 2021, 57 (08):
  • [42] COVID-19 vaccines and pregnancy: What do we know?
    Cottin, Judith
    Benevent, Justine
    Khettar, Sophie
    Lacroix, Isabelle
    THERAPIE, 2021, 76 (04): : 373 - 374
  • [43] Vasculitis and COVID-19: what do we have to know?
    Tamburello, Antonio
    Castelno, Laura
    Bizzi, Emanuele
    Caso, Francesco
    ITALIAN JOURNAL OF MEDICINE, 2020, 14 (04) : 213 - 215
  • [44] COVID-19 and stock market volatility: A time-varying perspective
    Topcu, Mert
    Yagli, Ibrahim
    Emirmahmutoglu, Furkan
    ECONOMICS BULLETIN, 2021, 41 (03): : 1681 - +
  • [45] COVID-19, gender and estroprogestins, what do we know?
    Fidecicchi, Tiziana
    Fruzzetti, Franca
    Lete Lasa, Luis Ignacio
    Calaf, Joaquim
    EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2022, 27 (01): : 67 - 74
  • [46] Anesthesia and COVID-19: What We Should Know and What We Should Do
    Tang, Linda Y.
    Wang, Jingping
    SEMINARS IN CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2020, 24 (02) : 127 - 137
  • [47] What Do We Currently Know About Chronic Myeloid Leukemia (CML) and COVID-19?
    Nancy Delgado
    Anahí Torres
    Current Oncology Reports, 2022, 24 : 645 - 650
  • [48] What do we know about covid-19 vaccines in under 5s?
    Cox, David
    BMJ-BRITISH MEDICAL JOURNAL, 2022, 378
  • [49] What do we know about IL-6 in COVID-19 so far?
    Jingrui Jiang
    Jun Wang
    Lulu Yao
    Shenghan Lai
    Xueji Zhang
    Biophysics Reports, 2021, 7 (03) : 193 - 206
  • [50] Psychological effects of the COVID-19 pandemic-what do we know about them?
    Glinianowicz, M.
    Ciura, D.
    Burnatowska, E.
    Olszanecka-glinianowicz, M.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (13) : 6445 - 6458